Astellas Pharma Inc. ALPMF
15.96 USD 0.00 (+0.00%)
At closeNov 11, 2026, 4:00 PM EST
Day range unavailable
11.40 52-week range 18.03
- YTD
- +21.18%
- 1 year
- +41.11%
News
benzinga.com Merck Advances European Regulatory Approval For Keytruda Combination In Bladder Cancer European committee backs Merck's Keytruda + Padcev combo for bladder cancer after Phase 3 trial slashes risk of recurrence by 47%.
benzinga.com These Analysts Boost Their Forecasts On Vir Biotechnology 
benzinga.com Why Is Monte Rosa Stock Trading Higher Today? Monte Rosa reports interim Phase 1/2 data showing durable responses and manageable safety for MRT-2359 plus Pfizer's Xtandi in advanced prostate cancer patients.
benzinga.com Why Is Taysha Gene Therapies Stock Falling Friday? Taysha Gene Therapies shares fall after regaining full rights to Rett syndrome drug TSHA-102 and finalizing FDA alignment for pivotal trial.
benzinga.com Stocks That Hit 52-Week Highs On Tuesday